Korro Bio (KRRO) Stock Forecast, Price Target & Predictions
KRRO Stock Forecast
Korro Bio stock forecast is as follows: an average price target of $105.00 (represents a 142.55% upside from KRRO’s last price of $43.29) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
KRRO Price Target
The average price target for Korro Bio (KRRO) is $105.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $105.00 to $105.00. This represents a potential 142.55% upside from KRRO's last price of $43.29.
KRRO Analyst Ratings
According to 6 Wall Street analysts, Korro Bio's rating consensus is 'Buy'. The analyst rating breakdown for KRRO stock is 1 'Strong Buy' (16.67%), 5 'Buy' (83.33%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Korro Bio Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | Luca Issi | RBC Capital | $105.00 | $76.94 | 36.47% | 142.55% |
| May 15, 2024 | Kostas Biliouris | BMO Capital | $120.00 | $50.05 | 139.76% | 177.20% |
| Mar 28, 2024 | H.C. Wainwright | $115.00 | $88.53 | 29.90% | 165.65% | |
| Mar 27, 2024 | RBC Capital | $90.00 | $89.83 | 0.19% | 107.90% |
The latest Korro Bio stock forecast, released on Oct 21, 2024 by Luca Issi from RBC Capital, set a price target of $105.00, which represents a 36.47% increase from the stock price at the time of the forecast ($76.94), and a 142.55% increase from KRRO last price ($43.29).
Korro Bio Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 4 |
| Avg Price Target | - | $105.00 | $107.50 |
| Last Closing Price | $43.29 | $43.29 | $43.29 |
| Upside/Downside | -100.00% | 142.55% | 148.33% |
In the current month, the average price target of Korro Bio stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Korro Bio's last price of $43.29. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 21, 2024 | Raymond James | Strong Buy | Initialise | |
| Oct 21, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Oct 18, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Oct 16, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Sep 17, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Sep 17, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Aug 15, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Aug 14, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 14, 2024 | William Blair | Outperform | Initialise | |
| May 15, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Mar 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Korro Bio's last stock rating was published by Raymond James on Oct 21, 2024. The company Initialise its KRRO rating from "null" to "Strong Buy".
Korro Bio Financial Forecast
Korro Bio Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
Korro Bio's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. KRRO's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Korro Bio EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict KRRO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Korro Bio's previous annual EBITDA (undefined) of $NaN.
Korro Bio Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Korro Bio's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. KRRO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Korro Bio SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Korro Bio's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to KRRO last annual SG&A of $NaN (undefined).
Korro Bio EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, Korro Bio's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to KRRO previous annual EPS of $NaN (undefined).